Nuzenio

Praxis

Praxis news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 16 publisher sources 100/100 entity strength

Latest news

Is Praxis (PRAX) Trading Bigger Losses for Long-Run CNS Ambition With Its Cash War Chest? - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 22:12:08 GMT Praxis: Commercial Launch Could Smash Expectations (Video) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 22:37:21 GMT RBC Adjusts PT on Praxis Precision Medicines to $462 From $449, Keeps Outperform Speculative Risk Rating - MoomooMoomoo · Fri, 07 Aug 2026 14:51:45 GMT The week on eprivateclient: Corient, Praxis, RSM and more... - Pam InsightPam Insight · Fri, 07 Aug 2026 14:22:23 GMT Deutsche Bank Adjusts Praxis Precision Medicines PT to $475 From $374, Maintains Buy Rating - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 13:38:06 GMT Praxis Precision Medicines Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 08:04:00 GMT Wedbush Adjusts PT on Praxis Precision Medicines to $188 From $162, Maintains Underperform Rating - MoomooMoomoo · Fri, 07 Aug 2026 04:47:24 GMT Praxis Precision Medicines, Inc. Stock 12‑Month Price Target Raised to $620.95, Implies 95% Upside - TradingViewTradingView · Thu, 06 Aug 2026 23:20:28 GMT

Timeline

Sat, 08 Aug 2026 22:12:08 GMTIs Praxis (PRAX) Trading Bigger Losses for Long-Run CNS Ambition With Its Cash War Chest? - Yahoo Finance

Fri, 07 Aug 2026 22:37:21 GMTPraxis: Commercial Launch Could Smash Expectations (Video) - Seeking Alpha

Fri, 07 Aug 2026 14:51:45 GMTRBC Adjusts PT on Praxis Precision Medicines to $462 From $449, Keeps Outperform Speculative Risk Rating - Moomoo

Fri, 07 Aug 2026 14:22:23 GMTThe week on eprivateclient: Corient, Praxis, RSM and more... - Pam Insight

Fri, 07 Aug 2026 13:38:06 GMTDeutsche Bank Adjusts Praxis Precision Medicines PT to $475 From $374, Maintains Buy Rating - marketscreener.com

Fri, 07 Aug 2026 08:04:00 GMTPraxis Precision Medicines Q2 Earnings Call Highlights - TradingView

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Praxis Precision Medicines16 live mentions PRAX6 live mentions From6 live mentions Medicines5 live mentions Inc5 live mentions Earnings Call Highlights4 live mentions TradingView Praxis Precision4 live mentions Financial Results3 live mentions The Manila Times3 live mentions CEO3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Praxis.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

16 distinct publisher/source names are currently connected to this entity page.